Trial Profile
Multicenter, Open-label Study of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Deoxycholic acid (Primary)
- Indications Subcutaneous fat disorders
- Focus Adverse reactions; Registrational
- Sponsors Kythera Biopharmaceuticals
- 11 Jun 2014 New trial record